The U.S. is at a crucial juncture in the opioid epidemic: overdoses are claiming more lives than ever, and the influx of funding from government sources and settled cases is imminent. This project seeks to develop strategies that ensure that incoming funding supports evidence-based, effective treatment and prevention, as well as harm reduction efforts and recovery supports.

Our Work

States are anticipating up to $26 billion in proceeds from settlements and judgments against opioid manufacturers and distributors over the next eighteen years. In order for these dollars to address the overdose crisis, ongoing commitment from the federal government, as well as states and localities, is essential to support individuals, families, and communities in achieving long-term recovery and resilience.

This project launched in September 2021 with the Opioid Litigation Summit, a first-of-its-kind convening of key experts from comprehensive, divergent, and cross-cutting fields to identify strategies to maximize proceeds from these litigations. It features tools developed in collaboration with experts and advocates from government, public health law and policy, and complex litigation, including a model state law, the Model Opioid Litigation Proceeds Act, to ensure litigation proceeds are spent on addressing the opioid crisis.

Our Team

Regina Labelle Headshot

Regina LaBelle Director

Shelly Weizman's headshot

Shelly Weizman Associate Director

Sonia Canzater Headshot

Sonia L. Canzater Associate Director

Taleed El-Sabawi Headshot

Taleed El-Sabawi Research Scholar

Former acting director of the White House Office of National Drug Control Policy, Regina LaBelle, discusses the Biden-Harris Administration’s strategy for addressing the overdose crisis.